Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH MM 2018 | MRD and disease eradication in myeloma

We spoke to Jesús San Miguel, MD, PhD, of the University of Navarra, Pamplona, Spain, to discuss the importance of measurable residual disease (MRD) in the eradication of multiple myeloma (MM). This interview was recorded at the European School of Haematology (ESH) International Conference on MM 2018, held in Mandelieu, France.